Xilio Therapeutics, Inc. (XLO) Reports 26% Response in Colon Cancer Drug Trial
Xilio Therapeutics, Inc.
Xilio Therapeutics Inc. (XLO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Balyasny Asset Management Dmitry Balyasny | 254,346 | $184,248 | -26% | 0% |
| 2. | Renaissance Technologies Jim Simons | 177,700 | $128,726 | -41% | 0% |
| 3. | Millennium Management Israel Englander | 51,110 | $37,024 | 0% | |
| 4. | Scientech Research Le Duan | 42,546 | $30,820 | 0.01% | |
| 5. | ADAR1 Capital Management Daniel Schneeberger | 40,000 | $28,976 | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.04 | 1,759,978 | Large Shareholder | 9,105,451 | 2024-12-18 | Filing | |
| $0.76 | 485,250 | Large Shareholder | 7,345,473 | 2024-04-02 | Filing | |
| $10.24 | 3,188 | Large Shareholder | 2,805,413 | 2021-12-10 | Filing | |
| $9.56 | 21,812 | Large Shareholder | 2,802,225 | 2021-12-10 | Filing | |
| $9.84 | 4,011 | Large Shareholder | 2,780,413 | 2021-12-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 6,954 | 12,421 | 2025-01-02 | Filing | ||
| $0.98 | 1,803 | 3,197 | 2025-01-02 | Filing | ||
| $0.64 | 267 | Large Shareholder | 734,546 | 2024-02-08 | Filing | |
| $0.64 | 733 | Large Shareholder | 2,019,563 | 2024-02-08 | Filing | |
| $0.83 | 560 | Large Shareholder | 734,813 | 2024-01-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,105,451 | $6,595,989 | 0.56% | |
| 2. | 4,566,817 | $3,308,202 | 0.49% | |
| 3. | 1,483,758 | $1,074,834 | 0.65% | |
| 4. | 1,475,121 | $1,067,988 | 6.59% | |
| 5. | 1,155,838 | $837,289 | 0% |
News See All
Billionaire Hedge Funds
